Work

Harnessing Lactobacillus reuteri ‐Derived Extracellular Vesicles for Multifaceted Cancer Treatment (Small 10/2025)

Year: 2025

Type: article

Abstract: Cancer Treatments Extracellular vesicles derived from the probiotic Lactobacillus reuteri (REVs) exhibit remarkable antitumor efficacy through oral administration, leveraging their stability in the gastrointestinal environment and inherent therapeutic effects. When combined with photothermal therapy, REVs encapsulating photosensitizers effectively target and eradicate lung tumors, highlighting their potential as a versatile platform for standalone or combinational cancer treatments. More in article number 2406094, Taejoon Kang, Juyeon Jung, and co-workers.

Source: Small

DOI: 10.1002/smll.202570073

Authors: Soyeon Yi, Eunkyeong Jung, Hyeran Kim, Jinsol Choi, Suhyeon Kim, Eun‐Kyung Lim, Kwang‐Sun Kim, Taejoon Kang, Juyeon Jung

Institutions: Korea Research Institute of Bioscience and Biotechnology, Korea University, Kyung Hee University, Sungkyunkwan University, Korea University of Science and Technology, Pusan National University

Language: English

Topic: Extracellular vesicles in disease

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4408364977

FWCI:

Cites:

Cited by:

Related to: 10